Annalora AJ - Search Results

1

Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.

Lidberg KA, Annalora AJ, Jozic M, Elson DJ, Wang L, Bammler TK, Ramm S, Monteiro MB, Himmelfarb J, Marcus CB, Iversen PL, Kelly EJ. Lidberg KA, et al. Among authors: annalora aj. Sci Rep. 2021 Feb 25;11(1):4722. doi: 10.1038/s41598-021-84194-w. Sci Rep. 2021. PMID: 33633318 Free PMC article.

2

Alternative splicing of the vitamin D receptor modulates target gene expression and promotes ligand-independent functions.

Annalora AJ, Jozic M, Marcus CB, Iversen PL. Annalora AJ, et al. Toxicol Appl Pharmacol. 2019 Feb 1;364:55-67. doi: 10.1016/j.taap.2018.12.009. Epub 2018 Dec 12. Toxicol Appl Pharmacol. 2019. PMID: 30552932

3

Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.

Lidberg KA, Annalora AJ, Jozic M, Elson DJ, Wang L, Bammler TK, Ramm S, Monteiro MB, Himmelfarb J, Marcus CB, Iversen PL, Kelly EJ. Lidberg KA, et al. Among authors: annalora aj. Sci Rep. 2021 May 17;11(1):10711. doi: 10.1038/s41598-021-90075-z. Sci Rep. 2021. PMID: 34002000 Free PMC article. No abstract available.

4

Alternative Splicing in the Cytochrome P450 Superfamily Expands Protein Diversity to Augment Gene Function and Redirect Human Drug Metabolism.

Annalora AJ, Marcus CB, Iversen PL. Annalora AJ, et al. Drug Metab Dispos. 2017 Apr;45(4):375-389. doi: 10.1124/dmd.116.073254. Epub 2017 Feb 10. Drug Metab Dispos. 2017. PMID: 28188297 Review.

5

Alternative Splicing in the Nuclear Receptor Superfamily Expands Gene Function to Refine Endo-Xenobiotic Metabolism.

Annalora AJ, Marcus CB, Iversen PL. Annalora AJ, et al. Drug Metab Dispos. 2020 Apr;48(4):272-287. doi: 10.1124/dmd.119.089102. Epub 2020 Jan 24. Drug Metab Dispos. 2020. PMID: 31980501 Review.

6

A k-mer based transcriptomics approach for antisense drug discovery targeting the Ewing's family of tumors.

Annalora AJ, O'Neil S, Bushman JD, Summerton JE, Marcus CB, Iversen PL. Annalora AJ, et al. Oncotarget. 2018 Jul 17;9(55):30568-30586. doi: 10.18632/oncotarget.25736. eCollection 2018 Jul 17. Oncotarget. 2018. PMID: 30093970 Free PMC article.

7

Cytochrome P450 1B1: A Key Regulator of Ocular Iron Homeostasis and Oxidative Stress.

Song YS, Annalora AJ, Marcus CB, Jefcoate CR, Sorenson CM, Sheibani N. Song YS, et al. Among authors: annalora aj. Cells. 2022 Sep 20;11(19):2930. doi: 10.3390/cells11192930. Cells. 2022. PMID: 36230892 Free PMC article. Review.

8

Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.

Annalora AJ, Bobrovnikov-Marjon E, Serda R, Pastuszyn A, Graham SE, Marcus CB, Omdahl JL. Annalora AJ, et al. Arch Biochem Biophys. 2007 Apr 15;460(2):262-73. doi: 10.1016/j.abb.2006.11.018. Epub 2006 Dec 3. Arch Biochem Biophys. 2007. PMID: 17207766 Free PMC article.

9

Rat cytochrome P450C24 (CYP24A1) and the role of F249 in substrate binding and catalytic activity.

Annalora A, Bobrovnikova-Marjon E, Serda R, Lansing L, Chiu ML, Pastuszyn A, Iyer S, Marcus CB, Omdahl JL. Annalora A, et al. Arch Biochem Biophys. 2004 May 15;425(2):133-46. doi: 10.1016/j.abb.2004.01.025. Arch Biochem Biophys. 2004. PMID: 15111121

10

Expression, structure-function, and molecular modeling of vitamin D P450s.

Omdahl JL, Bobrovnikova EV, Annalora A, Chen P, Serda R. Omdahl JL, et al. J Cell Biochem. 2003 Feb 1;88(2):356-62. doi: 10.1002/jcb.10366. J Cell Biochem. 2003. PMID: 12520537 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters